Analysts and mutual fund managers say the declines in the U.S. stock market in April 2014 focussing on tech and biotechs is healthy, as values of tech stocks and biotech stocks had gone up too fast. The pause in the market and even declines of 5-10%, as funds shift money to safer consumer, pharmaceutical and neglected large cap stocks, is likely to set the stock market up for further gains in the latter part of 2014, according to many analysts and mutual fund managers. Unlike 2000 and 2007 there are no similiar bubbles in the market, and the pause has helped clear some of excesses which is seen as beneficial, say fund managers.